Community pharmacists' perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis.

Autor:	Jairoun AA; Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates.; Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University of Science Malaysia (USM), Pulau Pinang, Malaysia., Al-Himyari SS; Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University of Science Malaysia (USM), Pulau Pinang, Malaysia.; Pharmacy Department, Emirates Health Services, Dubai, United Arab Emirates., Shahwan M; Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates., Al Ani M; Department of Developmental Biology and Cancer, Great Ormond Street Institute of Child Health, Faculty of Population Health Sciences, University College London, London, United Kingdom., Habeb M; Edgware Community Hospital, Edgware, United Kingdom., Jairoun M; Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates., Zyoud SH; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.; Clinical Research Centre, An-Najah National University Hospital, Nablus, Palestine., Alkhanani MF; Department of Biology, College of Science, University of Hafr Al Batin, Hafr Al-Batin, Saudi Arabia., Alhasani RH; Department of Biology, College of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia., Hakami AY; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia., Ainousah BA; Pharmaceutical Chemistry Department, College of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia., Alshehri FS; Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al Qura University, Mecca, Saudi Arabia., Alorfi NM; Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al Qura University, Mecca, Saudi Arabia., Suliman A; College of Dentistry, Ajman University, Ajman, United Arab Emirates.
Jazyk:	angličtina
Zdroj:	Frontiers in pharmacology [Front Pharmacol] 2023 Sep 05; Vol. 14, pp. 1237717. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
DOI:	10.3389/fphar.2023.1237717
Abstrakt:	Background: Community pharmacists play an intermediary role between prescribing physicians and patients in the United Arab Emirates (UAE) and thus are responsible for ensuring that patients receive optimal cardiovascular disease (CVD) pharmaceutical care. Methods: we used a cross-sectional design to assess the perceptions and practices of community pharmacists concerning pharmaceutical care for patients with CVD. A trained researcher visited randomly selected community pharmacies and used a structured questionnaire to conduct in-person interviews with pharmacists. The questionnaire collected demographic data and information on perceptions and practices regarding CVD pharmaceutical care. Results: Five hundred and fifty-one participants were recruited. The average participant age (mean ± SD) was 35 ± 2.7 years. The average perception score regarding CVD prevention and management was 75.6% (95% confidence interval [CI] 77.1%-74.2%), and the average practice score for CVD prevention and management was 87.1% (95% CI 76.5%-79.6%). Bivariate analysis revealed that gender ( p = 0.001), education level ( p < 0.001), pharmacy position ( p = 0.004), work experience ( p < 0.001), number of patients served per day ( p < 0.001) and being trained on CVD prevention and management ( p < 0.001) were significantly associated with perceptions about the prevention and management of CVD. Better practice scores were seen among older participants (OR 1.01; 95% CI 1-1.019), postgraduates (OR 1.77; 95% CI 1.66-1.89), workers at chain pharmacies (OR 1.24; 95% CI 1.11-1.39), pharmacists in charge (OR 1.22; 95% CI 1.01-1.47), pharmacists with >10 years of experience (OR 11.3; 95% CI 6.01-15.62), pharmacists with 6-10 years of experience (OR 4.42; 95% CI 3.90-5) and pharmacists trained on CVD prevention and management (OR 1.29; 95% CI 1.15-1.46). Conclusion: Pharmacy practitioners working in community pharmacies in the UAE actively engage in delivering pharmaceutical care to patients, playing a role in CVD management and prevention. However, they showed low levels of involvement in other healthcare services, specifically in screening and measuring patients' weight, glucose levels, and blood pressure, monitoring treatment responses, maintaining medical records, and reviewing medication refill histories. Activities such as educating patients, providing medication counseling, offering support for treatment adherence, and fostering collaborative relationships with other healthcare providers should be encouraged among UAE community pharmacists to ensure the provision of high-quality patient care. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Jairoun, Al-Himyari, Shahwan, Al Ani, Habeb, Jairoun, Zyoud, Alkhanani, Alhasani, Hakami, Ainousah, Alshehri, Alorfi and Suliman.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu